PeptideStack
5.2kquestions
20kanswers
220users

harm-reduction

Page 20 of 20 · 472 questions tagged harm-reduction.

NewestActiveVotesUnanswered

472 questions · sorted by votes · page 20 of 20

3 votes0 answers2.5k views
Is a date of analysis from QST sufficient basis to skip independent testing?

The particulars: date of analysis · QST. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsasked by nominal_ten 12k · 13 months ago
3 votes 1 answer2.2k views
What should be in place before a first mazdutide vial arrives from Nantong?

The specifics, since they change the answer: mazdutide · Nantong. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsresearch-use-only
research-use-only

What "for research use only" means as a legal and practical designation: not approved for human use, no pharmacopoeial release testing, no…

95 questionssterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

142 questionsmazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questionsasked by tare_and_weigh 12k · 8 months ago
3 votes5 answers2k views
Does the PIONEER-4 population resemble anyone asking about oral semaglutide here?

Conditions: PIONEER-4 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questionsoral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questionsasked by threadlock7 19k · 8 days ago
3 votes 2 answers1k views
Is headache on tirzepatide dose-dependent or dose-rate dependent?

Conditions: headache · tirzepatide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionstirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questionsasked by noor_alhassan 11k · 16 days ago
2 votes5 answers24k views
What is the reported incidence of headache on semaglutide in STEP 5?

Stated plainly: headache · semaglutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questionsasked by two_two_micron 9.3k · 2.3 years ago
2 votes5 answers19k views
Does the STEP 1 population resemble anyone asking about semaglutide here?

The case in front of me: STEP 1 · semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questionsasked by area_percent 9.9k · 21 months ago
2 votes 4 answers19k views
How do I tell biliary colic from ordinary upper-abdominal discomfort?

For the avoidance of doubt, nothing here is urgent — I would be in a clinic rather than a text box. The figures are clear enough; the question is what they mean and…

gallbladder
gallbladder

Cholelithiasis and cholecystitis risk during rapid weight loss and on treatment: how much is attributable to the rate of loss versus to the drug,…

8 questionsgi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsasked by oona_kekkonen 13k · 2.3 years ago
2 votes 5 answers9.4k views
Is a list of related substances from GL Biochem sufficient basis to skip independent testing?

Setup, so nobody has to ask: list of related substances · GL Biochem. I want to decide this in advance so that I am not deciding it under pressure later. Assume I…

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsasked by rota_site 36k · 2.3 years ago
2 votes5 answers8.1k views
What accept/reject threshold would you set for survodutide before seeing the result?

The lot number on the vial matches the certificate, which at least rules out the easy problem. The failure mode I am trying to avoid is making this decision…

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionscoa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questionssurvodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questionsasked by drawn_and_capped 12k · 13 months ago
2 votes 5 answers7.1k views
What interval makes sense for repeating ALT on mazdutide?

What I have: ALT · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsa1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questionsliver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questionsmazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questionsasked by swab_and_wait 13k · 10 months ago
2 votes5 answers3.9k views
Is aspiration indicated for a subcutaneous injection?

I keep a written log of every draw with date, volume and syringe type. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…

injection-technique
injection-technique

Technique questions: angle, pinch versus flat, aspiration, injection speed, air bubbles, and the handling steps that determine whether you deliver…

96 questionssubcutaneous
subcutaneous

Subcutaneous administration as a route: absorption kinetics from abdomen versus thigh versus upper arm, tissue depth, and why site rotation…

10 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsasked by coldpack_88 50k · 4 months ago
2 votes5 answers2.1k views
Is rounding to the nearest whole unit an acceptable error?

I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile. I understand the observation; what I do not understand is the…

dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questionsinsulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

244 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsasked by ten_mg_vial 31k · 3 months ago
2 votes0 answers1.2k views
What is a sensible monitoring routine for dulaglutide over eight weeks?

Conditions: dulaglutide · eight weeks. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my tolerance…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsplateau
plateau

A stall in progress: distinguishing adaptive thermogenesis from measurement error from adherence drift, how long to observe before changing…

36 questionsdulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questionsasked by per_haugen 13k · 18 months ago
1 vote 5 answers9k views
Does the PIONEER-1 population resemble anyone asking about a GLP-1 receptor agonist here?

What I am working with: PIONEER-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questionsasked by leah_ferrers 12k · 8 months ago
1 vote 5 answers4.7k views
Is a laboratory refrigerator good enough for storing reconstituted cagrilintide?

For reference: a laboratory refrigerator · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight,…

storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questionscold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsamylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questionsasked by otto_brenner 12k · 8 months ago
1 vote2 answers756 views
Is creatinine worth drawing at baseline before starting mazdutide?

For reference: creatinine · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questionsharm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questionsa1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questionskidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questionsmazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questionsasked by felix_araya 6.8k · 34 days ago